Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 240

1.

INTRAMYOCARDIAL BONE MARROW STEM CELLS IN PATIENTS UNDERGOING CARDIAC SURGICAL REVASCULARIZATION.

Chan JL, Miller JG, Zhou Y, Robey PG, Stroncek DF, Arai AE, Sachdev V, Horvath KA.

Ann Thorac Surg. 2019 Sep 14. pii: S0003-4975(19)31394-3. doi: 10.1016/j.athoracsur.2019.07.093. [Epub ahead of print]

PMID:
31526779
2.

Neonatal McCune-Albright Syndrome: A Unique Syndromic Profile With an Unfavorable Outcome.

Corsi A, Cherman N, Donaldson DL, Robey PG, Collins MT, Riminucci M.

JBMR Plus. 2019 Jan 15;3(8):e10134. doi: 10.1002/jbm4.10134. eCollection 2019 Aug.

3.

Advances in stem cell research and therapeutic development.

De Luca M, Aiuti A, Cossu G, Parmar M, Pellegrini G, Robey PG.

Nat Cell Biol. 2019 Jul;21(7):801-811. doi: 10.1038/s41556-019-0344-z. Epub 2019 Jun 17. Review.

PMID:
31209293
4.

Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation.

Guo L, Bertola DR, Takanohashi A, Saito A, Segawa Y, Yokota T, Ishibashi S, Nishida Y, Yamamoto GL, Franco JFDS, Honjo RS, Kim CA, Musso CM, Timmons M, Pizzino A, Taft RJ, Lajoie B, Knight MA, Fischbeck KH, Singleton AB, Ferreira CR, Wang Z, Yan L, Garbern JY, Simsek-Kiper PO, Ohashi H, Robey PG, Boyde A, Matsumoto N, Miyake N, Spranger J, Schiffmann R, Vanderver A, Nishimura G, Passos-Bueno MRDS, Simons C, Ishikawa K, Ikegawa S.

Am J Hum Genet. 2019 May 2;104(5):925-935. doi: 10.1016/j.ajhg.2019.03.004. Epub 2019 Apr 11.

PMID:
30982609
5.

In Vivo Formation of Stable Hyaline Cartilage by Naïve Human Bone Marrow Stromal Cells with Modified Fibrin Microbeads.

Kuznetsov SA, Hailu-Lazmi A, Cherman N, de Castro LF, Robey PG, Gorodetsky R.

Stem Cells Transl Med. 2019 Jun;8(6):586-592. doi: 10.1002/sctm.18-0129. Epub 2019 Feb 14.

6.

Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden.

de Castro LF, Burke AB, Wang HD, Tsai J, Florenzano P, Pan KS, Bhattacharyya N, Boyce AM, Gafni RI, Molinolo AA, Robey PG, Collins MT.

J Bone Miner Res. 2019 Feb;34(2):290-294. doi: 10.1002/jbmr.3602. Epub 2018 Nov 29.

PMID:
30496606
7.

Proceedings of the signature series symposium "cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies-promise, facts and fantasy," international society for cellular therapies, montreal, canada, may 2, 2018.

Piuzzi NS, Dominici M, Long M, Pascual-Garrido C, Rodeo S, Huard J, Guicheux J, McFarland R, Goodrich LR, Maddens S, Robey PG, Bauer TW, Barrett J, Barry F, Karli D, Chu CR, Weiss DJ, Martin I, Jorgensen C, Muschler GF.

Cytotherapy. 2018 Nov;20(11):1381-1400. doi: 10.1016/j.jcyt.2018.09.001. Epub 2018 Oct 10.

PMID:
30316562
8.

Combinatorial cassettes to systematically evaluate tissue-engineered constructs in recipient mice.

Bodhak S, de Castro LF, Kuznetsov SA, Azusa M, Bonfim D, Robey PG, Simon CG Jr.

Biomaterials. 2018 Dec;186:31-43. doi: 10.1016/j.biomaterials.2018.09.035. Epub 2018 Sep 24.

PMID:
30278344
9.

Clear up this stem-cell mess.

Sipp D, Robey PG, Turner L.

Nature. 2018 Sep;561(7724):455-457. doi: 10.1038/d41586-018-06756-9. No abstract available.

PMID:
30258150
10.

Continuing Challenges in Advancing Preclinical Science in Skeletal Cell-Based Therapies and Tissue Regeneration.

Featherall J, Robey PG, Rowe DW.

J Bone Miner Res. 2018 Oct;33(10):1721-1728. doi: 10.1002/jbmr.3578. Epub 2018 Sep 4.

11.

Pluripotent Stem Cell Platforms for Drug Discovery.

Chen KG, Mallon BS, Park K, Robey PG, McKay RDG, Gottesman MM, Zheng W.

Trends Mol Med. 2018 Sep;24(9):805-820. doi: 10.1016/j.molmed.2018.06.009. Epub 2018 Jul 11. Review.

12.

Comparison of human bone marrow stromal cells cultured in human platelet growth factors and fetal bovine serum.

Ren J, Ward D, Chen S, Tran K, Jin P, Sabatino M, Robey PG, Stroncek DF.

J Transl Med. 2018 Mar 14;16(1):65. doi: 10.1186/s12967-018-1400-3.

13.

Mouse Genetic Analysis of Bone Marrow Stem Cell Niches: Technological Pitfalls, Challenges, and Translational Considerations.

Chen KG, Johnson KR, Robey PG.

Stem Cell Reports. 2017 Nov 14;9(5):1343-1358. doi: 10.1016/j.stemcr.2017.09.014. Epub 2017 Oct 19. Review.

14.

Concise Review: Conceptualizing Paralogous Stem-Cell Niches and Unfolding Bone Marrow Progenitor Cell Identities.

Chen KG, Johnson KR, McKay RDG, Robey PG.

Stem Cells. 2018 Jan;36(1):11-21. doi: 10.1002/stem.2711. Epub 2017 Oct 12. Review.

15.

Bisphosphonate-induced zebra lines in fibrous dysplasia of bone: histo-radiographic correlation in a case of McCune-Albright syndrome.

Corsi A, Ippolito E, Robey PG, Riminucci M, Boyde A.

Skeletal Radiol. 2017 Oct;46(10):1435-1439. doi: 10.1007/s00256-017-2698-2. Epub 2017 Jun 28.

16.

Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple Centers.

Liu S, de Castro LF, Jin P, Civini S, Ren J, Reems JA, Cancelas J, Nayak R, Shaw G, O'Brien T, McKenna DH, Armant M, Silberstein L, Gee AP, Hei DJ, Hematti P, Kuznetsov SA, Robey PG, Stroncek DF.

Sci Rep. 2017 Apr 27;7:46731. doi: 10.1038/srep46731.

17.

Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo.

Pievani A, Sacchetti B, Corsi A, Rambaldi B, Donsante S, Scagliotti V, Vergani P, Remoli C, Biondi A, Robey PG, Riminucci M, Serafini M.

Development. 2017 Mar 15;144(6):1035-1044. doi: 10.1242/dev.142836.

18.

No Identical "Mesenchymal Stem Cells" at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels.

Sacchetti B, Funari A, Remoli C, Giannicola G, Kogler G, Liedtke S, Cossu G, Serafini M, Sampaolesi M, Tagliafico E, Tenedini E, Saggio I, Robey PG, Riminucci M, Bianco P.

Stem Cell Reports. 2016 Jun 14;6(6):897-913. doi: 10.1016/j.stemcr.2016.05.011.

19.

Paolo Bianco (1955-2015).

Robey PG, Riminucci M, Boyde A, Sipp D.

Cell Stem Cell. 2015 Dec 3;17(6):649-50. No abstract available.

20.

Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States.

Chen RJ, Zhang G, Garfield SH, Shi YJ, Chen KG, Robey PG, Leapman RD.

PLoS One. 2015 Nov 13;10(11):e0142554. doi: 10.1371/journal.pone.0142554. eCollection 2015.

21.

Missense mutation in the PTEN promoter of a patient with hemifacial hyperplasia.

Yamazaki K, Eng C, Kuznetsov SA, Reinisch J, Yamashita DD, Walker J, Cheung C, Robey PG, Yen SL.

Bonekey Rep. 2015 Jul 29;4:654. doi: 10.1038/bonekey.2015.21. eCollection 2015.

22.

Impaired function of bone marrow stromal cells in systemic mastocytosis.

Nemeth K, Wilson TM, Ren JJ, Sabatino M, Stroncek DM, Krepuska M, Bai Y, Robey PG, Metcalfe DD, Mezey E.

Stem Cell Res. 2015 Jul;15(1):42-53. doi: 10.1016/j.scr.2015.04.005. Epub 2015 May 8.

23.

Mice Deficient in AKAP13 (BRX) Are Osteoporotic and Have Impaired Osteogenesis.

Koide H, Holmbeck K, Lui JC, Guo XC, Driggers P, Chu T, Tatsuno I, Quaglieri C, Kino T, Baron J, Young MF, Robey PG, Segars JH.

J Bone Miner Res. 2015 Oct;30(10):1887-95. doi: 10.1002/jbmr.2534. Epub 2015 May 10.

24.

Human bone marrow stromal cell confluence: effects on cell characteristics and methods of assessment.

Ren J, Wang H, Tran K, Civini S, Jin P, Castiello L, Feng J, Kuznetsov SA, Robey PG, Sabatino M, Stroncek DF.

Cytotherapy. 2015 Jul;17(7):897-911. doi: 10.1016/j.jcyt.2015.03.607. Epub 2015 Apr 14.

25.

WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt Signaling.

Maeda A, Ono M, Holmbeck K, Li L, Kilts TM, Kram V, Noonan ML, Yoshioka Y, McNerny EM, Tantillo MA, Kohn DH, Lyons KM, Robey PG, Young MF.

J Biol Chem. 2015 May 29;290(22):14004-18. doi: 10.1074/jbc.M114.628818. Epub 2015 Apr 11.

26.

Molecular profile of clonal strains of human skeletal stem/progenitor cells with different potencies.

Sworder BJ, Yoshizawa S, Mishra PJ, Cherman N, Kuznetsov SA, Merlino G, Balakumaran A, Robey PG.

Stem Cell Res. 2015 May;14(3):297-306. doi: 10.1016/j.scr.2015.02.005. Epub 2015 Feb 25.

27.

Skeletal stem cells.

Bianco P, Robey PG.

Development. 2015 Mar 15;142(6):1023-7. doi: 10.1242/dev.102210. Review.

28.

Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo.

Amarnath S, Foley JE, Farthing DE, Gress RE, Laurence A, Eckhaus MA, Métais JY, Rose JJ, Hakim FT, Felizardo TC, Cheng AV, Robey PG, Stroncek DE, Sabatino M, Battiwalla M, Ito S, Fowler DH, Barrett AJ.

Stem Cells. 2015 Apr;33(4):1200-12. doi: 10.1002/stem.1934.

29.

p53 loss increases the osteogenic differentiation of bone marrow stromal cells.

He Y, de Castro LF, Shin MH, Dubois W, Yang HH, Jiang S, Mishra PJ, Ren L, Gou H, Lal A, Khanna C, Merlino G, Lee M, Robey PG, Huang J.

Stem Cells. 2015 Apr;33(4):1304-19. doi: 10.1002/stem.1925.

30.

Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.

Balakumaran A, Mishra PJ, Pawelczyk E, Yoshizawa S, Sworder BJ, Cherman N, Kuznetsov SA, Bianco P, Giri N, Savage SA, Merlino G, Dumitriu B, Dunbar CE, Young NS, Alter BP, Robey PG.

Blood. 2015 Jan 29;125(5):793-802. doi: 10.1182/blood-2014-06-566810. Epub 2014 Dec 12.

31.

Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.

Remoli C, Michienzi S, Sacchetti B, Consiglio AD, Cersosimo S, Spica E, Robey PG, Holmbeck K, Cumano A, Boyde A, Davis G, Saggio I, Riminucci M, Bianco P.

J Bone Miner Res. 2015 Jun;30(6):1030-43. doi: 10.1002/jbmr.2425.

32.

Stem cells and bone diseases: new tools, new perspective.

Riminucci M, Remoli C, Robey PG, Bianco P.

Bone. 2015 Jan;70:55-61. doi: 10.1016/j.bone.2014.09.009. Epub 2014 Sep 18. Review.

33.

Alternative cultures for human pluripotent stem cell production, maintenance, and genetic analysis.

Chen KG, Hamilton RS, Robey PG, Mallon BS.

J Vis Exp. 2014 Jul 24;(89). doi: 10.3791/51519.

34.

Generation of clinical grade human bone marrow stromal cells for use in bone regeneration.

Robey PG, Kuznetsov SA, Ren J, Klein HG, Sabatino M, Stroncek DF.

Bone. 2015 Jan;70:87-92. doi: 10.1016/j.bone.2014.07.020. Epub 2014 Jul 24.

35.

A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone.

Boyce AM, Kelly MH, Brillante BA, Kushner H, Wientroub S, Riminucci M, Bianco P, Robey PG, Collins MT.

J Clin Endocrinol Metab. 2014 Nov;99(11):4133-40. doi: 10.1210/jc.2014-1371. Epub 2014 Jul 17.

36.

Directed differentiation of human induced pluripotent stem cells toward bone and cartilage: in vitro versus in vivo assays.

Phillips MD, Kuznetsov SA, Cherman N, Park K, Chen KG, McClendon BN, Hamilton RS, McKay RD, Chenoweth JG, Mallon BS, Robey PG.

Stem Cells Transl Med. 2014 Jul;3(7):867-78. doi: 10.5966/sctm.2013-0154. Epub 2014 May 22.

37.

Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model.

Hong SG, Winkler T, Wu C, Guo V, Pittaluga S, Nicolae A, Donahue RE, Metzger ME, Price SD, Uchida N, Kuznetsov SA, Kilts T, Li L, Robey PG, Dunbar CE.

Cell Rep. 2014 May 22;7(4):1298-1309. doi: 10.1016/j.celrep.2014.04.019. Epub 2014 May 15.

38.

Constitutive expression of Gsα(R201C) in mice produces a heritable, direct replica of human fibrous dysplasia bone pathology and demonstrates its natural history.

Saggio I, Remoli C, Spica E, Cersosimo S, Sacchetti B, Robey PG, Holmbeck K, Cumano A, Boyde A, Bianco P, Riminucci M.

J Bone Miner Res. 2014 Nov;29(11):2357-68. doi: 10.1002/jbmr.2267.

39.

Developmental insights from early mammalian embryos and core signaling pathways that influence human pluripotent cell growth and differentiation.

Chen KG, Mallon BS, Johnson KR, Hamilton RS, McKay RD, Robey PG.

Stem Cell Res. 2014 May;12(3):610-21. doi: 10.1016/j.scr.2014.02.002. Epub 2014 Feb 19. Review.

40.

Bone marrow stromal cell assays: in vitro and in vivo.

Robey PG, Kuznetsov SA, Riminucci M, Bianco P.

Methods Mol Biol. 2014;1130:279-293. doi: 10.1007/978-1-62703-989-5_21. Erratum in: Methods Mol Biol. 2014;1130:E3.

41.

Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.

Yin F, Battiwalla M, Ito S, Feng X, Chinian F, Melenhorst JJ, Koklanaris E, Sabatino M, Stroncek D, Samsel L, Klotz J, Hensel NF, Robey PG, Barrett AJ.

Stem Cells. 2014 May;32(5):1278-88. doi: 10.1002/stem.1638.

42.

Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics.

Chen KG, Mallon BS, McKay RD, Robey PG.

Cell Stem Cell. 2014 Jan 2;14(1):13-26. doi: 10.1016/j.stem.2013.12.005. Review.

43.

Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin.

Mallon BS, Hamilton RS, Kozhich OA, Johnson KR, Fann YC, Rao MS, Robey PG.

Stem Cell Res. 2014 Mar;12(2):376-86. doi: 10.1016/j.scr.2013.11.010. Epub 2013 Dec 4.

44.

Biglycan modulates angiogenesis and bone formation during fracture healing.

Berendsen AD, Pinnow EL, Maeda A, Brown AC, McCartney-Francis N, Kram V, Owens RT, Robey PG, Holmbeck K, de Castro LF, Kilts TM, Young MF.

Matrix Biol. 2014 Apr;35:223-31. doi: 10.1016/j.matbio.2013.12.004. Epub 2013 Dec 25.

45.

Establishing a bone marrow stromal cell transplant program at the National Institutes of Health Clinical Center.

Stroncek DF, Sabatino M, Ren J, England L, Kuznetsov SA, Klein HG, Robey PG.

Tissue Eng Part B Rev. 2014 Jun;20(3):200-5. doi: 10.1089/ten.TEB.2013.0529. Epub 2014 Feb 7. Review.

46.

WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone.

Ono M, Inkson CA, Sonn R, Kilts TM, de Castro LF, Maeda A, Fisher LW, Robey PG, Berendsen AD, Li L, McCartney-Francis N, Brown AC, Crawford NP, Molinolo A, Jain A, Fedarko NS, Young MF.

PLoS One. 2013 Aug 14;8(8):e71709. doi: 10.1371/journal.pone.0071709. eCollection 2013.

47.

Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence.

Ren J, Stroncek DF, Zhao Y, Jin P, Castiello L, Civini S, Wang H, Feng J, Tran K, Kuznetsov SA, Robey PG, Sabatino M.

Stem Cell Res. 2013 Nov;11(3):1060-73. doi: 10.1016/j.scr.2013.07.005. Epub 2013 Jul 27.

48.

Regulation of stem cell therapies under attack in Europe: for whom the bell tolls.

Bianco P, Barker R, Brüstle O, Cattaneo E, Clevers H, Daley GQ, De Luca M, Goldstein L, Lindvall O, Mummery C, Robey PG, Sattler de Sousa E Brito C, Smith A.

EMBO J. 2013 May 29;32(11):1489-95. doi: 10.1038/emboj.2013.114. Epub 2013 May 3.

49.

Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome.

Zhao W, Petit E, Gafni RI, Collins MT, Robey PG, Seton M, Miller KK, Mannstadt M.

Osteoporos Int. 2013 Aug;24(8):2275-81. doi: 10.1007/s00198-013-2298-5. Epub 2013 Feb 7.

50.

The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine.

Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, Simmons PJ, Wang CY.

Nat Med. 2013 Jan;19(1):35-42. doi: 10.1038/nm.3028. Epub 2013 Jan 7.

Supplemental Content

Loading ...
Support Center